Designing drugs for parasitic diseases of the developing world

PLoS Medicine

Volumn 2, Issue 8, 2005, Pages 0712-0714

  McKerrow, James H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; CHLOROQUINE;

AFRICAN TRYPANOSOMIASIS; DRUG INDUSTRY; DRUG RESEARCH; HEALTH CARE ORGANIZATION; MALARIA; NON PROFIT ORGANIZATION; PARASITOSIS; SHORT SURVEY; ARTICLE; DEVELOPING COUNTRY; DRUG DESIGN; ECONOMICS; HUMAN;

ANTIPARASITIC AGENTS; DEVELOPING COUNTRIES; DRUG DESIGN; HUMANS; PARASITIC DISEASES;

EID: 33750518467     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.0020210     Document Type: Short Survey

References (4)

1. World Health Organization, United Nations Children's Fund (2003) Africa malaria report 2003. Available: http://www.rbm.who.int/amd2003/amr2003/amr_toc. htm. Accessed 11 May 2005.
2. Colley DG, LoVerde PT, Savioli L (2001) Infectious disease. Medical helminthologyin the 21st century. Science 293: 1437-1438.
3. King CH, Dickman K, Tisch DJ (2005) Reassessment of the cost of chronic helminthic infection: A meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365: 1561-1569.
4. Pécoul B (2004) New drugs for neglected diseases: From pipeline to patients. PLoS Med 1: e6. DOI: 10.1371/journal.pmed.0010006